Global Influenza Virus Vaccine (H1N1) Market Research Report 2020

Global Influenza Virus Vaccine (H1N1) Market Research Report 2020

Table of Contents
1 Influenza Virus Vaccine (H1N1) Market Overview
1.1 Product Overview and Scope of Influenza Virus Vaccine (H1N1)
1.2 Influenza Virus Vaccine (H1N1) Segment by Type
1.2.1 Global Influenza Virus Vaccine (H1N1) Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Intramuscular Vaccine
1.2.3 Nasal Spray Vaccine
1.3 Influenza Virus Vaccine (H1N1) Segment by Application
1.3.1 Influenza Virus Vaccine (H1N1) Sales Comparison by Application: 2020 VS 2026
1.3.2 3 To 10 Years Old
1.3.3 10 To 18 Years Old
1.3.4 Above 18 Years Old
1.3.5 Other
1.4 Global Influenza Virus Vaccine (H1N1) Market Size Estimates and Forecasts
1.4.1 Global Influenza Virus Vaccine (H1N1) Revenue 2015-2026
1.4.2 Global Influenza Virus Vaccine (H1N1) Sales 2015-2026
1.4.3 Influenza Virus Vaccine (H1N1) Market Size by Region: 2020 Versus 2026
2 Global Influenza Virus Vaccine (H1N1) Market Competition by Manufacturers
2.1 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Manufacturers (2015-2020)
2.2 Global Influenza Virus Vaccine (H1N1) Revenue Share by Manufacturers (2015-2020)
2.3 Global Influenza Virus Vaccine (H1N1) Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Influenza Virus Vaccine (H1N1) Manufacturing Sites, Area Served, Product Type
2.5 Influenza Virus Vaccine (H1N1) Market Competitive Situation and Trends
2.5.1 Influenza Virus Vaccine (H1N1) Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Influenza Virus Vaccine (H1N1) Players (Opinion Leaders)
3 Influenza Virus Vaccine (H1N1) Retrospective Market Scenario by Region
3.1 Global Influenza Virus Vaccine (H1N1) Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Influenza Virus Vaccine (H1N1) Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country
3.3.1 North America Influenza Virus Vaccine (H1N1) Sales by Country
3.3.2 North America Influenza Virus Vaccine (H1N1) Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country
3.4.1 Europe Influenza Virus Vaccine (H1N1) Sales by Country
3.4.2 Europe Influenza Virus Vaccine (H1N1) Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Influenza Virus Vaccine (H1N1) Market Facts & Figures by Region
3.5.1 Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Region
3.5.2 Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country
3.6.1 Latin America Influenza Virus Vaccine (H1N1) Sales by Country
3.6.2 Latin America Influenza Virus Vaccine (H1N1) Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country
3.7.1 Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country
3.7.2 Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Influenza Virus Vaccine (H1N1) Historic Market Analysis by Type
4.1 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2015-2020)
4.2 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2015-2020)
4.3 Global Influenza Virus Vaccine (H1N1) Price Market Share by Type (2015-2020)
4.4 Global Influenza Virus Vaccine (H1N1) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Influenza Virus Vaccine (H1N1) Historic Market Analysis by Application
5.1 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2015-2020)
5.2 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Application (2015-2020)
5.3 Global Influenza Virus Vaccine (H1N1) Price by Application (2015-2020)
6 Company Profiles and Key Figures in Influenza Virus Vaccine (H1N1) Business
6.1 CSL
6.1.1 Corporation Information
6.1.2 CSL Description, Business Overview and Total Revenue
6.1.3 CSL Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020)
6.1.4 CSL Products Offered
6.1.5 CSL Recent Development
6.2 NVS(Novartis)
6.2.1 NVS(Novartis) Influenza Virus Vaccine (H1N1) Production Sites and Area Served
6.2.2 NVS(Novartis) Description, Business Overview and Total Revenue
6.2.3 NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020)
6.2.4 NVS(Novartis) Products Offered
6.2.5 NVS(Novartis) Recent Development
6.3 Sanofi Pasteur
6.3.1 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Production Sites and Area Served
6.3.2 Sanofi Pasteur Description, Business Overview and Total Revenue
6.3.3 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Sanofi Pasteur Products Offered
6.3.5 Sanofi Pasteur Recent Development
6.4 Medimmune
6.4.1 Medimmune Influenza Virus Vaccine (H1N1) Production Sites and Area Served
6.4.2 Medimmune Description, Business Overview and Total Revenue
6.4.3 Medimmune Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Medimmune Products Offered
6.4.5 Medimmune Recent Development
6.5 GSK
6.5.1 GSK Influenza Virus Vaccine (H1N1) Production Sites and Area Served
6.5.2 GSK Description, Business Overview and Total Revenue
6.5.3 GSK Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020)
6.5.4 GSK Products Offered
6.5.5 GSK Recent Development
6.6 Baxter
6.6.1 Baxter Influenza Virus Vaccine (H1N1) Production Sites and Area Served
6.6.2 Baxter Description, Business Overview and Total Revenue
6.6.3 Baxter Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Baxter Products Offered
6.6.5 Baxter Recent Development
6.7 Beijing Kexing Bio-Vaccine
6.6.1 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Production Sites and Area Served
6.6.2 Beijing Kexing Bio-Vaccine Description, Business Overview and Total Revenue
6.6.3 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Beijing Kexing Bio-Vaccine Products Offered
6.7.5 Beijing Kexing Bio-Vaccine Recent Development
6.8 Hualan Bio-Vaccine
6.8.1 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Production Sites and Area Served
6.8.2 Hualan Bio-Vaccine Description, Business Overview and Total Revenue
6.8.3 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Hualan Bio-Vaccine Products Offered
6.8.5 Hualan Bio-Vaccine Recent Development
6.9 Changchun Changsheng Bio-Technology
6.9.1 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Production Sites and Area Served
6.9.2 Changchun Changsheng Bio-Technology Description, Business Overview and Total Revenue
6.9.3 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Changchun Changsheng Bio-Technology Products Offered
6.9.5 Changchun Changsheng Bio-Technology Recent Development
6.10 Beijing Tiantan Bio-Products
6.10.1 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Production Sites and Area Served
6.10.2 Beijing Tiantan Bio-Products Description, Business Overview and Total Revenue
6.10.3 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Beijing Tiantan Bio-Products Products Offered
6.10.5 Beijing Tiantan Bio-Products Recent Development
6.11 Jiangsu Yanshen Bio-Technology
6.11.1 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Production Sites and Area Served
6.11.2 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Description, Business Overview and Total Revenue
6.11.3 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Jiangsu Yanshen Bio-Technology Products Offered
6.11.5 Jiangsu Yanshen Bio-Technology Recent Development
6.12 Zhejiang Tianyuan Bio-Pharmaceutical
6.12.1 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Production Sites and Area Served
6.12.2 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Description, Business Overview and Total Revenue
6.12.3 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Zhejiang Tianyuan Bio-Pharmaceutical Products Offered
6.12.5 Zhejiang Tianyuan Bio-Pharmaceutical Recent Development
6.13 Dalian Yalifeng Bio-Pharmaceutical
6.13.1 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Production Sites and Area Served
6.13.2 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Description, Business Overview and Total Revenue
6.13.3 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Dalian Yalifeng Bio-Pharmaceutical Products Offered
6.13.5 Dalian Yalifeng Bio-Pharmaceutical Recent Development
6.14 Sinopharm
6.14.1 Sinopharm Influenza Virus Vaccine (H1N1) Production Sites and Area Served
6.14.2 Sinopharm Influenza Virus Vaccine (H1N1) Description, Business Overview and Total Revenue
6.14.3 Sinopharm Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Sinopharm Products Offered
6.14.5 Sinopharm Recent Development
7 Influenza Virus Vaccine (H1N1) Manufacturing Cost Analysis
7.1 Influenza Virus Vaccine (H1N1) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Influenza Virus Vaccine (H1N1)
7.4 Influenza Virus Vaccine (H1N1) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Influenza Virus Vaccine (H1N1) Distributors List
8.3 Influenza Virus Vaccine (H1N1) Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Influenza Virus Vaccine (H1N1) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Influenza Virus Vaccine (H1N1) by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Influenza Virus Vaccine (H1N1) by Type (2021-2026)
10.2 Influenza Virus Vaccine (H1N1) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Influenza Virus Vaccine (H1N1) by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Influenza Virus Vaccine (H1N1) by Application (2021-2026)
10.3 Influenza Virus Vaccine (H1N1) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Influenza Virus Vaccine (H1N1) by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Influenza Virus Vaccine (H1N1) by Region (2021-2026)
10.4 North America Influenza Virus Vaccine (H1N1) Estimates and Projections (2021-2026)
10.5 Europe Influenza Virus Vaccine (H1N1) Estimates and Projections (2021-2026)
10.6 Asia Pacific Influenza Virus Vaccine (H1N1) Estimates and Projections (2021-2026)
10.7 Latin America Influenza Virus Vaccine (H1N1) Estimates and Projections (2021-2026)
10.8 Middle East and Africa Influenza Virus Vaccine (H1N1) Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) Comparison by Application: 2020 VS 2026
Table 3. Global Influenza Virus Vaccine (H1N1) Market Size by Type (K Doses) (US$ Million) (2020 VS 2026)
Table 4. Global Key Influenza Virus Vaccine (H1N1) Manufacturers Covered in This Study
Table 5. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) by Manufacturers (2015-2020)
Table 6. Global Influenza Virus Vaccine (H1N1) Sales Share by Manufacturers (2015-2020)
Table 7. Global Influenza Virus Vaccine (H1N1) Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Influenza Virus Vaccine (H1N1) Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Influenza Virus Vaccine (H1N1) Average Price (US$/Dose) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Influenza Virus Vaccine (H1N1) Sales Sites and Area Served
Table 11. Manufacturers Influenza Virus Vaccine (H1N1) Product Types
Table 12. Global Influenza Virus Vaccine (H1N1) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Influenza Virus Vaccine (H1N1) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Virus Vaccine (H1N1) as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Influenza Virus Vaccine (H1N1) Players
Table 16. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) by Region (2015-2020)
Table 17. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2015-2020)
Table 18. Global Influenza Virus Vaccine (H1N1) Revenue (Million US$) by Region (2015-2020)
Table 19. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2015-2020)
Table 20. North America Influenza Virus Vaccine (H1N1) Sales by Country (2015-2020) (K Doses)
Table 21. North America Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2015-2020)
Table 22. North America Influenza Virus Vaccine (H1N1) Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2015-2020)
Table 24. Europe Influenza Virus Vaccine (H1N1) Sales by Country (2015-2020) (K Doses)
Table 25. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2015-2020)
Table 26. Europe Influenza Virus Vaccine (H1N1) Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Region (2015-2020) (K Doses)
Table 29. Asia Pacific Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2015-2020)
Table 32. Latin America Influenza Virus Vaccine (H1N1) Sales by Country (2015-2020) (K Doses)
Table 33. Latin America Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2015-2020)
Table 34. Latin America Influenza Virus Vaccine (H1N1) Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country (2015-2020) (K Doses)
Table 37. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2015-2020)
Table 40. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) by Type (2015-2020)
Table 41. Global Influenza Virus Vaccine (H1N1) Sales Share by Type (2015-2020)
Table 42. Global Influenza Virus Vaccine (H1N1) Revenue (Million US$) by Type (2015-2020)
Table 43. Global Influenza Virus Vaccine (H1N1) Revenue Share by Type (2015-2020)
Table 44. Global Influenza Virus Vaccine (H1N1) Price (US$/Dose) by Type (2015-2020)
Table 45. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) by Application (2015-2020)
Table 46. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2015-2020)
Table 47. Global Influenza Virus Vaccine (H1N1) Sales Growth Rate by Application (2015-2020)
Table 48. CSL Influenza Virus Vaccine (H1N1) Corporation Information
Table 49. CSL Description and Business Overview
Table 50. CSL Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 51. CSL Main Product
Table 52. CSL Recent Development
Table 53. NVS(Novartis) Influenza Virus Vaccine (H1N1) Corporation Information
Table 54. NVS(Novartis) Corporation Information
Table 55. NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 56. NVS(Novartis) Main Product
Table 57. NVS(Novartis) Recent Development
Table 58. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Corporation Information
Table 59. Sanofi Pasteur Corporation Information
Table 60. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 61. Sanofi Pasteur Main Product
Table 62. Sanofi Pasteur Recent Development
Table 63. Medimmune Influenza Virus Vaccine (H1N1) Corporation Information
Table 64. Medimmune Corporation Information
Table 65. Medimmune Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 66. Medimmune Main Product
Table 67. Medimmune Recent Development
Table 68. GSK Influenza Virus Vaccine (H1N1) Corporation Information
Table 69. GSK Corporation Information
Table 70. GSK Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 71. GSK Main Product
Table 72. GSK Recent Development
Table 73. Baxter Influenza Virus Vaccine (H1N1) Corporation Information
Table 74. Baxter Corporation Information
Table 75. Baxter Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 76. Baxter Main Product
Table 77. Baxter Recent Development
Table 78. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Corporation Information
Table 79. Beijing Kexing Bio-Vaccine Corporation Information
Table 80. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 81. Beijing Kexing Bio-Vaccine Main Product
Table 82. Beijing Kexing Bio-Vaccine Recent Development
Table 83. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Corporation Information
Table 84. Hualan Bio-Vaccine Corporation Information
Table 85. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 86. Hualan Bio-Vaccine Main Product
Table 87. Hualan Bio-Vaccine Recent Development
Table 88. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Corporation Information
Table 89. Changchun Changsheng Bio-Technology Corporation Information
Table 90. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 91. Changchun Changsheng Bio-Technology Main Product
Table 92. Changchun Changsheng Bio-Technology Recent Development
Table 93. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Corporation Information
Table 94. Beijing Tiantan Bio-Products Corporation Information
Table 95. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 96. Beijing Tiantan Bio-Products Main Product
Table 97. Beijing Tiantan Bio-Products Recent Development
Table 98. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Corporation Information
Table 99. Jiangsu Yanshen Bio-Technology Corporation Information
Table 100. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 101. Jiangsu Yanshen Bio-Technology Main Product
Table 102. Jiangsu Yanshen Bio-Technology Recent Development
Table 103. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Corporation Information
Table 104. Zhejiang Tianyuan Bio-Pharmaceutical Corporation Information
Table 105. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 106. Zhejiang Tianyuan Bio-Pharmaceutical Main Product
Table 107. Zhejiang Tianyuan Bio-Pharmaceutical Recent Development
Table 108. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Corporation Information
Table 109. Dalian Yalifeng Bio-Pharmaceutical Corporation Information
Table 110. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 111. Dalian Yalifeng Bio-Pharmaceutical Main Product
Table 112. Dalian Yalifeng Bio-Pharmaceutical Recent Development
Table 113. Sinopharm Influenza Virus Vaccine (H1N1) Corporation Information
Table 114. Sinopharm Corporation Information
Table 115. Sinopharm Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 116. Sinopharm Main Product
Table 117. Sinopharm Recent Development
Table 118. Sales Base and Market Concentration Rate of Raw Material
Table 119. Key Suppliers of Raw Materials
Table 120. Influenza Virus Vaccine (H1N1) Distributors List
Table 121. Influenza Virus Vaccine (H1N1) Customers List
Table 122. Market Key Trends
Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 124. Key Challenges
Table 125. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) Forecast by Type (2021-2026)
Table 126. Global Influenza Virus Vaccine (H1N1) Sales Market Share Forecast by Type (2021-2026)
Table 127. Global Influenza Virus Vaccine (H1N1) Revenue (Million US$) Forecast by Type (2021-2026)
Table 128. Global Influenza Virus Vaccine (H1N1) Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 129. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) Forecast by Application (2021-2026)
Table 130. Global Influenza Virus Vaccine (H1N1) Revenue (Million US$) Forecast by Application (2021-2026)
Table 131. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) Forecast by Region (2021-2026)
Table 132. Global Influenza Virus Vaccine (H1N1) Sales Market Share Forecast by Region (2021-2026)
Table 133. Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 134. Global Influenza Virus Vaccine (H1N1) Revenue Market Share Forecast by Region (2021-2026)
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Influenza Virus Vaccine (H1N1)
Figure 2. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type: 2020 VS 2026
Figure 3. Intramuscular Vaccine Product Picture
Figure 4. Nasal Spray Vaccine Product Picture
Figure 5. Global Influenza Virus Vaccine (H1N1) Consumption Market Share by Application: 2020 VS 2026
Figure 6. 3 To 10 Years Old
Figure 7. 10 To 18 Years Old
Figure 8. Above 18 Years Old
Figure 9. Other
Figure 10. Global Influenza Virus Vaccine (H1N1) Market Size 2015-2026 (US$ Million)
Figure 11. Global Influenza Virus Vaccine (H1N1) Sales Capacity (K Doses) (2015-2026)
Figure 12. Global Influenza Virus Vaccine (H1N1) Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Influenza Virus Vaccine (H1N1) Sales Share by Manufacturers in 2020
Figure 14. Global Influenza Virus Vaccine (H1N1) Revenue Share by Manufacturers in 2019
Figure 15. The Global 5 and 10 Largest Players: Market Share by Influenza Virus Vaccine (H1N1) Revenue in 2019
Figure 16. Influenza Virus Vaccine (H1N1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2015-2020)
Figure 18. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region in 2019
Figure 19. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2015-2020)
Figure 20. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Region in 2019
Figure 21. North America Influenza Virus Vaccine (H1N1) Sales Market Share by Country in 2019
Figure 22. North America Influenza Virus Vaccine (H1N1) Revenue Market Share by Country in 2019
Figure 23. U.S. Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
Figure 24. U.S. Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Canada Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
Figure 26. Canada Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Country in 2019
Figure 28. Europe Influenza Virus Vaccine (H1N1) Revenue Market Share by Country in 2019
Figure 29. Germany Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
Figure 30. Germany Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. France Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
Figure 32. France Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. U.K. Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
Figure 34. U.K. Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Italy Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
Figure 36. Italy Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Russia Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
Figure 38. Russia Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Asia Pacific Influenza Virus Vaccine (H1N1) Sales Market Share by Region in 2019
Figure 40. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue Market Share by Region in 2019
Figure 41. China Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
Figure 42. China Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Japan Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
Figure 44. Japan Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. South Korea Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
Figure 46. South Korea Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. India Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
Figure 48. India Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Australia Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
Figure 50. Australia Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Taiwan Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
Figure 52. Taiwan Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Indonesia Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
Figure 54. Indonesia Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Thailand Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
Figure 56. Thailand Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Malaysia Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
Figure 58. Malaysia Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Philippines Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
Figure 60. Philippines Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Vietnam Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
Figure 62. Vietnam Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Latin America Influenza Virus Vaccine (H1N1) Sales Market Share by Country in 2019
Figure 64. Latin America Influenza Virus Vaccine (H1N1) Revenue Market Share by Country in 2019
Figure 65. Mexico Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
Figure 66. Mexico Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Brazil Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
Figure 68. Brazil Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Argentina Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
Figure 70. Argentina Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Country in 2019
Figure 72. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue Market Share by Country in 2019
Figure 73. Turkey Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
Figure 74. Turkey Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Saudi Arabia Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
Figure 76. Saudi Arabia Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. UAE Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses)
Figure 78. UAE Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Sales Market Share of Influenza Virus Vaccine (H1N1) by Type (2015-2020)
Figure 80. Sales Market Share of Influenza Virus Vaccine (H1N1) by Type in 2019
Figure 81. Revenue Share of Influenza Virus Vaccine (H1N1) by Type (2015-2020)
Figure 82. Revenue Market Share of Influenza Virus Vaccine (H1N1) by Type in 2019
Figure 83. Global Influenza Virus Vaccine (H1N1) Sales Growth by Type (2015-2020) (K Doses)
Figure 84. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2015-2020)
Figure 85. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application in 2019
Figure 86. Global Revenue Share of Influenza Virus Vaccine (H1N1) by Application (2015-2020)
Figure 87. Global Revenue Share of Influenza Virus Vaccine (H1N1) by Application in 2020
Figure 88. CSL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. NVS(Novartis) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Sanofi Pasteur Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Medimmune Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Baxter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Beijing Kexing Bio-Vaccine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Hualan Bio-Vaccine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Changchun Changsheng Bio-Technology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Beijing Tiantan Bio-Products Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Jiangsu Yanshen Bio-Technology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Zhejiang Tianyuan Bio-Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Dalian Yalifeng Bio-Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Sinopharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Price Trend of Key Raw Materials
Figure 103. Manufacturing Cost Structure of Influenza Virus Vaccine (H1N1)
Figure 104. Manufacturing Process Analysis of Influenza Virus Vaccine (H1N1)
Figure 105. Influenza Virus Vaccine (H1N1) Industrial Chain Analysis
Figure 106. Channels of Distribution

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs